Informatie:
Fout:
ID
18139
Beschrijving
Xcellerated T CellsTM in Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00078065
Link
https://clinicaltrials.gov/show/NCT00078065
Trefwoorden
Versies (1)
- 22-10-16 22-10-16 -
Geüploaded op
22 oktober 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Multiple Myeloma NCT00078065
Eligibility Multiple Myeloma NCT00078065
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma NCT00078065
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Multiple Myeloma | Systemic therapy Quantity failed | Recurrent disease | Disease Progression | Transplantation of autologous hematopoietic stem cell | Neoadjuvant Therapy | high-dose chemotherapy
Item
failure of at least one, but no more than four, prior systemic therapies for mm prior to registration and may not have relapsed or progressed within 1 year following autologous hematopoietic stem cell transplantation. repeat courses of the same therapeutic regimen separated in time by 6 or more months are considered separate therapies. induction therapy followed by high dose chemotherapy and autologous hematopoietic stem cell transplantation counts as one therapy.
boolean
C0026764 (UMLS CUI [1])
C1515119 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
C0277556 (UMLS CUI [3])
C0242656 (UMLS CUI [4])
C1831743 (UMLS CUI [5])
C0600558 (UMLS CUI [6])
C1328050 (UMLS CUI [7])
C1515119 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
C0277556 (UMLS CUI [3])
C0242656 (UMLS CUI [4])
C1831743 (UMLS CUI [5])
C0600558 (UMLS CUI [6])
C1328050 (UMLS CUI [7])
M Protein Serum Measurable | M Protein Urine Measurable
Item
measurable serum and/or urine m-protein
boolean
C0700271 (UMLS CUI [1,1])
C0229671 (UMLS CUI [1,2])
C1513040 (UMLS CUI [1,3])
C0700271 (UMLS CUI [2,1])
C0042036 (UMLS CUI [2,2])
C1513040 (UMLS CUI [2,3])
C0229671 (UMLS CUI [1,2])
C1513040 (UMLS CUI [1,3])
C0700271 (UMLS CUI [2,1])
C0042036 (UMLS CUI [2,2])
C1513040 (UMLS CUI [2,3])
Disease Progression | Recurrent disease | Therapeutic procedure Multiple Myeloma
Item
disease progression or relapse, since most recent therapy for multiple myeloma
boolean
C0242656 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0026764 (UMLS CUI [3,2])
C0277556 (UMLS CUI [2])
C0087111 (UMLS CUI [3,1])
C0026764 (UMLS CUI [3,2])
Age
Item
age > 18 years old and < 75 years old
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Childbearing Potential Serum pregnancy test (B-HCG) Negative | Childbearing Potential Contraceptive methods | Contraceptives, Oral, Hormonal | Intrauterine Devices | Vaginal contraceptive diaphragm | Vaginal Spermicides | Female Condoms | Sexual Abstinence
Item
females of child-bearing potential must have a negative serum bhcg test and be willing to use effective contraception (i.e., a hormonal contraceptive, intra-uterine device, diaphragm with spermicide, condom with spermicide, or abstinence) for the duration of the trial
boolean
C3831118 (UMLS CUI [1,1])
C0430060 (UMLS CUI [1,2])
C1513916 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0009907 (UMLS CUI [3])
C0021900 (UMLS CUI [4])
C0042241 (UMLS CUI [5])
C0087145 (UMLS CUI [6])
C0221829 (UMLS CUI [7])
C0036899 (UMLS CUI [8])
C0430060 (UMLS CUI [1,2])
C1513916 (UMLS CUI [1,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0009907 (UMLS CUI [3])
C0021900 (UMLS CUI [4])
C0042241 (UMLS CUI [5])
C0087145 (UMLS CUI [6])
C0221829 (UMLS CUI [7])
C0036899 (UMLS CUI [8])
HIV-1 infection Negative Test Result | HIV-2 infection Negative Test Result | Human T-lymphotropic virus 1 Negative Test Result | Human T-lymphotropic virus 2 Negative Test Result | Hepatitis B Negative Test Result | Hepatitis C Negative Test Result | Antibody test Acceptable | Antigen test Acceptable | Nucleic Acid Testing Acceptable
Item
negative test results for current/active infection with hiv-1, hiv-2, htlv-1, htlv-2, hepatitis b, and hepatitis c within 30 days of registration (antibody, antigen, and nucleic acid tests acceptable, depending on institutional standards)
boolean
C2363741 (UMLS CUI [1,1])
C1334932 (UMLS CUI [1,2])
C0854094 (UMLS CUI [2,1])
C1334932 (UMLS CUI [2,2])
C0020094 (UMLS CUI [3,1])
C1334932 (UMLS CUI [3,2])
C0020099 (UMLS CUI [4,1])
C1334932 (UMLS CUI [4,2])
C0019163 (UMLS CUI [5,1])
C1334932 (UMLS CUI [5,2])
C0019196 (UMLS CUI [6,1])
C1334932 (UMLS CUI [6,2])
C0580327 (UMLS CUI [7,1])
C1879533 (UMLS CUI [7,2])
C0729856 (UMLS CUI [8,1])
C1879533 (UMLS CUI [8,2])
C0200932 (UMLS CUI [9,1])
C1879533 (UMLS CUI [9,2])
C1334932 (UMLS CUI [1,2])
C0854094 (UMLS CUI [2,1])
C1334932 (UMLS CUI [2,2])
C0020094 (UMLS CUI [3,1])
C1334932 (UMLS CUI [3,2])
C0020099 (UMLS CUI [4,1])
C1334932 (UMLS CUI [4,2])
C0019163 (UMLS CUI [5,1])
C1334932 (UMLS CUI [5,2])
C0019196 (UMLS CUI [6,1])
C1334932 (UMLS CUI [6,2])
C0580327 (UMLS CUI [7,1])
C1879533 (UMLS CUI [7,2])
C0729856 (UMLS CUI [8,1])
C1879533 (UMLS CUI [8,2])
C0200932 (UMLS CUI [9,1])
C1879533 (UMLS CUI [9,2])
Hemoglobin | Red Blood Cell Transfusion | Erythropoietin
Item
hemoglobin >= 10.0 g/dl. transfusion with red blood cells or use of erythropoietin is permissible.
boolean
C0019046 (UMLS CUI [1])
C0086252 (UMLS CUI [2])
C0014822 (UMLS CUI [3])
C0086252 (UMLS CUI [2])
C0014822 (UMLS CUI [3])
White Blood Cell Count procedure | Absolute neutrophil count
Item
white blood count (wbc) >= 3,000/mm3 and absolute neutrophil count (anc) > 1000/mm3
boolean
C0023508 (UMLS CUI [1])
C0948762 (UMLS CUI [2])
C0948762 (UMLS CUI [2])
Platelet Count measurement
Item
platelet count > 75,000/mm3
boolean
C0032181 (UMLS CUI [1])
Corrected serum calcium measurement | Hypercalcemia Symptomatic Evidence | Serum calcium measurement
Item
corrected serum calcium < 11 mg/dl, and no evidence of symptomatic hypercalcemia. (corrected serum calcium is calculated by adding 0.8 mg/dl to the measured serum calcium for every 1 g/dl that the serum albumin falls below 4.0 g/dl)
boolean
C0455288 (UMLS CUI [1])
C0020437 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C3887511 (UMLS CUI [2,3])
C0728876 (UMLS CUI [3])
C0020437 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C3887511 (UMLS CUI [2,3])
C0728876 (UMLS CUI [3])
Serum total bilirubin measurement | Alanine aminotransferase measurement
Item
serum total bilirubin and alanine aminotransferase (alt) < 2.0 times the upper limit of normal
boolean
C1278039 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0201836 (UMLS CUI [2])
Creatinine measurement, serum
Item
serum creatinine < 2.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Human anti-mouse antibody Serologic titer Undetectable | Human anti-mouse antibody Serologic titer Normal | Hypersensitivity Mus | Hypersensitivity murine protein
Item
serum human anti-mouse antibody (hama) titer undetectable or within the normal range, and no history of allergies to mice or murine (mouse) proteins
boolean
C1291910 (UMLS CUI [1,1])
C0312544 (UMLS CUI [1,2])
C3827727 (UMLS CUI [1,3])
C1291910 (UMLS CUI [2,1])
C0312544 (UMLS CUI [2,2])
C0205307 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0026809 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C1699668 (UMLS CUI [4,2])
C0312544 (UMLS CUI [1,2])
C3827727 (UMLS CUI [1,3])
C1291910 (UMLS CUI [2,1])
C0312544 (UMLS CUI [2,2])
C0205307 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0026809 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C1699668 (UMLS CUI [4,2])
Informed Consent
Item
the patient must be able to comprehend and have signed the informed consent
boolean
C0021430 (UMLS CUI [1])